1 results match your criteria: "The Affiliated Huaian N0.1 People's Hospital of Nanjing Medical University[Affiliation]"
DLX6 Antisense RNA 1 Modulates Glucose Metabolism and Cell Growth in Gastric Cancer by Targeting microRNA-4290.
Dig Dis Sci
February 2021
Department of Gastric, The Affiliated Huaian N0.1 People's Hospital of Nanjing Medical University, No. 1 Huanghe West Road, Huaiyin District, Huai'an City, 223300, Jiangsu Province, China.
Background: Gastric cancer (GC) is one of the most commonly diagnosed malignancy worldwide. DLX6 antisense RNA 1 (DLX6-AS1) is a long noncoding RNA (lncRNA) that exhibits oncogenic effects on multiple human carcinomas.
Aims: This study aimed to investigate the regulatory effect of DLX6-AS1 in GC progression.